Back to Top

About

Dr. Kelsey's research interests are in the coordination of multicenter clinical trials and registries primarily in cardiology, but also in diabetes, women's health, neurology, and ophthalmology. She has served as Principal Investigator for coordinating centers for a number of National Institutes of Health-sponsored multicenter clinical trials and registries. She has served on over thirty Data and Safety Monitoring Boards for the National Institutes of Health, the Veteran's Administration and industry.

View More >>

Skills

Experience

Organization
Professor Emerita

University of Pittsburgh School of Public Health

Jan-2012 to Present

Publication

  • dott image February, 2019

Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women

Background: Currently as many as one-half of women with suspected myocardial ischemia have no obstructive coronary artery disease (CAD), and abnormal coronary reactivity (CR) is commonly fo...

  • dott image December, 2017

Ten-Year Mortality in the WISE Study (Women’s Ischemia Syndrome Evaluation)

Background— The WISE study (Women’s Ischemia Syndrome Evaluation) was a prospective cohort study of 936 clinically stable symptomatic women who underwent coronary angiography to evaluat...

Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women...

Background Women with signs and symptoms of ischemia, no obstructive coronary artery disease (CAD) and preserved left ventricular ejection fraction (EF) often have diastolic dysfunction and...

  • dott image February, 2017

Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE)

Objective: Studies have linked vasomotor symptoms (VMS) to markers of cardiovascular disease (CVD) risk, yet few have considered clinical cardiovascular events. Data suggest that associati...

  • dott image January, 2017

SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial

Background: The extent of coronary disease affects clinical outcomes and may predict the effectiveness of coronary revascularization with either coronary artery bypass graft (CABG) surgery ...

  • dott image September, 2016

Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome

Background: Women with polycystic ovary syndrome (PCOS) have greater cardiac risk factor clustering but the link with mortality is incompletely described. Objective: To evaluate outcomes in...

  • dott image February, 2014

Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored ...

Background Women are more likely than men to develop resistant hypertension, which is associated with excess risk of major adverse outcomes; however, the impact of resistant hypertension in...

Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: Findings from the National Hea...

Background Women presenting with signs and symptoms of myocardial ischemia frequently have no or nonobstructive coronary artery disease (CAD). Objective This study aimed to investigate th...

  • dott image January, 2012

Safety of Coronary Reactivity Testing in Women With No Obstructive Coronary Artery Disease: Results From the NHLBI-Sponsored WISE (Women's Ischemia Sy...

Objectives: This study evaluated the safety of coronary reactivity testing (CRT) in symptomatic women with evidence of myocardial ischemia and no obstructive coronary artery disease (CAD). ...

  • dott image October, 2011

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition ...

Background We investigated the role of the renin-angiotensin system in women with signs and symptoms of ischemia without obstructive coronary artery disease (CAD). Although microvascular dy...